Evidence map›Paper›PMID 36932248›Full record

ArticleNature medicine2023

Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.

Jeremy Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey, Halis K Akturk, Leslie J Klaff, Julio Rosenstock, Mickie H M Cheng, Bruce W Bode and 6 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 1 country.

Jeremy PettusDivision of Endocrinology, University of California San Diego, La Jolla, CA, USA. jpettus@health.ucsd.edu.ORCID http://orcid.org/0000-0002-5999-0091
Schafer C BoederDivision of Endocrinology, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-6221-7796
Mark P ChristiansenDiablo Clinical Research, Walnut Creek, CA, USA.
Douglas S DenhamClinical Trials of Texas, San Antonio, TX, USA.
Timothy S BaileyAMCR Institute, Escondido, CA, USA.ORCID http://orcid.org/0000-0003-4178-3462
Halis K AkturkBarbara Davis Center for Diabetes, University of Colorado Anschutz Campus, Aurora, CO, USA.ORCID http://orcid.org/0000-0003-4518-5179
Leslie J KlaffRainier Clinical Research Center, Renton, WA, USA.
Julio RosenstockDallas Diabetes Research Center, Dallas, TX, USA.
Mickie H M ChengMarin Endocrine Care and Research, Greenbrae, CA, USA.
Bruce W BodeAtlanta Diabetes Associates, Atlanta, GA, USA.
Edgar D BautistaREMD Biotherapeutics, Camarillo, CA, USA.
Ren XuREMD Biotherapeutics, Camarillo, CA, USA.
Hai YanREMD Biotherapeutics, Camarillo, CA, USA.
Dung ThaiREMD Biotherapeutics, Camarillo, CA, USA.
Satish K GargBarbara Davis Center for Diabetes, University of Colorado Anschutz Campus, Aurora, CO, USA.
Samuel KleinCenter for Human Nutrition, Washington University School of Medicine, St. Louis, MO and Sansum Diabetes Research Institute, Santa Barbara, CA, USA.
University of Colorado Anschutz Medical Campus · USAMCR Institute · USAtlanta Diabetes Associates · USClinical Trials of Texas · USDallas Diabetes Research Center · USDiablo Clinical Research · USMarin Endocrine Care and Research · USRainier Clinical Research Center · USSansum Diabetes Research Institute · USUC San Diego Health System · USUniversity of California San Diego · US

Funding

Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 DiabetesR44DK108305 · NIDDK · REMD BIOTHERAPEUTICS, INC. · PI KLEIN, SAMUEL, THAI, DUNG "ZUNG" · 2019 to 2021
$3.0M
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R44DK108305
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36932248
OpenAlexW4327811802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.